Can omentin-1 be a prognostic marker in surgical intensive care patients?
Open Access
- 21 October 2021
- journal article
- research article
- Published by The Scientific and Technological Research Council of Turkey (TUBITAK-ULAKBIM) - DIGITAL COMMONS JOURNALS in TURKISH JOURNAL OF MEDICAL SCIENCES
- Vol. 51 (5) , 2485-2493
Abstract
Background/aim: A member of the adipokine family, omentin-1 is selectively secreted from visceral fat tissue and the omentum. It has been shown that omentin-1 is involved in the pathogenesis of certain diseases and can be used as a prognostic marker. This study first investigated the prognostic significance of omentin-1 in surgical intensive care patients. In addition, the relationship between omentin-1 and laboratory and clinical parameters commonly used in intensive care units (ICUs) was evaluated. Materials and methods: One hundred and fifty-four patients hospitalized in the surgical ICU were included in the study. Blood samples for omentin-1 were collected from the patients displaying clinical condition changes. Changes in omentin-1 levels were observed during the hospital stay of the patients. A total of 423 blood samples were evaluated. Omentin-1 levels were compared to the laboratory parameters routinely monitored in the ICU and the prognostic significance of omentin-1 for surgical intensive care patients was investigated. Results: The median APACHE II score of all patients was (median-IQR, 8.0-6.0 ng/mL). Omentin-1 levels of the alive patients in the ICU (median-IQR, 339.04-407.68 ng/mL) were significantly higher compared to dead patients (median-IQR, 166.40-363.60 ng/ mL). Omentin-1 levels were higher in nonsepsis patients compared to the levels of the patients in sepsis and septic shock (p < 0.001). Omentin-1 values were negatively correlated with the C-reactive protein and procalcitonin levels, body temperature, and the SOFA (sequential organ failure assessment score) scores and they were positively correlated with albumin, prealbumin, and glucose levels. Conclusion: Omentin-1 may play a role in the complex constructs of inflammation and metabolic events in intensive care patients. Reduced omentin-1 levels in surgical intensive care patients were associated with poor prognosis and increased mortality.Keywords
This publication has 17 references indexed in Scilit:
- The Third International Consensus Definitions for Sepsis and Septic Shock (Sepsis-3)JAMA, 2016
- Impact of serum omentin-1 levels on cardiac prognosis in patients with heart failureCardiovascular Diabetology, 2014
- Serum omentin-1, inflammation and carotid atherosclerosis in patients with non-diabetic chronic kidney diseaseRenal Failure, 2013
- Association of serum omentin-1 levels with coronary artery diseaseActa Pharmacologica Sinica, 2011
- Omentin, a novel adipocytokine inhibits TNF-induced vascular inflammation in human endothelial cellsBiochemical and Biophysical Research Communications, 2011
- Serum adiponectin upon admission to the intensive care unit may predict mortality in critically ill patientsJournal of Critical Care, 2011
- Metformin Treatment May Increase Omentin-1 Levels in Women With Polycystic Ovary SyndromeDiabetes, 2010
- Vaspin and omentin: new adipokines differentially regulated at the site of inflammation in rheumatoid arthritisAnnals of the Rheumatic Diseases, 2010
- Changes of serum omentin-1 levels in normal subjects and in patients with impaired glucose regulation and with newly diagnosed and untreated type 2 diabetesDiabetes Research and Clinical Practice, 2010
- Omentin Plasma Levels and Gene Expression Are Decreased in ObesityDiabetes, 2007